Covid-19 roundup: Gilead aims remdesivir toward helping India outbreak; Merck pairs with 5 Indian generics manufacturers for molnupiravir
As the number of Covid-19 cases in India dramatically increases, Gilead will donate 450,000 vials of its remdesivir drug to the government.
The company announced the move in a release on Monday. Gilead is offering technical assistance support for new local manufacturing facilities and donations of APIs to scale up the production of the drug — commercially named Veklury — to help cut down on the recent surge.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.